These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 6490416)

  • 1. Thioridazine pharmacodynamics: clinical effects may depend upon drug metabolism.
    Lewis MH; Mobilio JN; Rissmiller DJ; Mailman RB
    J Am Osteopath Assoc; 1984 Sep; 84(1 Suppl):124-8. PubMed ID: 6490416
    [No Abstract]   [Full Text] [Related]  

  • 2. Greater potency of mesoridazine and sulforidazine compared with the parent compound, thioridazine, on striatal dopamine autoreceptors.
    Niedzwiecki DM; Mailman RB; Cubeddu LX
    J Pharmacol Exp Ther; 1984 Mar; 228(3):636-9. PubMed ID: 6707914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of thioridazine and its metabolites on dopaminergic function: drug metabolism as a determinant of the antidopaminergic actions of thioridazine.
    Kilts CD; Knight DL; Mailman RB; Widerlöv E; Breese GR
    J Pharmacol Exp Ther; 1984 Nov; 231(2):334-42. PubMed ID: 6491985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on thioridazine and mesoridazine metabolism. II. In vivo metabolism of tritiated drugs in rhesus monkeys.
    Forrest IS; Green DE; Blum A; Serra MT; Loeffler KO
    Commun Psychopharmacol; 1979; 3(5):323-7. PubMed ID: 121276
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on thioridazine and mesoridazine metabolism. I. Protein binding.
    Forrest IS; Green DE; Blum A; Serra MT; Loeffler KO
    Commun Psychopharmacol; 1979; 3(5):319-22. PubMed ID: 548210
    [No Abstract]   [Full Text] [Related]  

  • 6. Absorption and excretion of thioridazine and mesoridazine in man.
    Charalampous KD; Johnson PC; Estevez V
    Dis Nerv Syst; 1974 Nov; 35(11):494-6. PubMed ID: 17896456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesoridazine and thioridazine.
    Richelson E
    J Clin Psychiatry; 1987 Aug; 48(8):344. PubMed ID: 3038853
    [No Abstract]   [Full Text] [Related]  

  • 8. Isolation of a possible new metabolite of thioridazine and mesoridazine from human plasma.
    Dinovo EC; Gottschalk LA; Noble EP; Biener R
    Res Commun Chem Pathol Pharmacol; 1974 Mar; 7(3):489-96. PubMed ID: 4824823
    [No Abstract]   [Full Text] [Related]  

  • 9. GLC analysis of thioridazine, mesoridazine, and their metabolites.
    Dinovo EC; Gottschalk LA; Nandi BR; Geddes PG
    J Pharm Sci; 1976 May; 65(5):667-9. PubMed ID: 932933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a metabolite of thioridazine and mesoridazine from human plasma.
    Gruenke LD; Craig JC
    Res Commun Chem Pathol Pharmacol; 1975 Feb; 10(2):221-5. PubMed ID: 1162173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Albumin binding of thioridazine and some of its metabolites.
    Vandeheeren FA; Belpaire FM
    Arch Int Pharmacodyn Ther; 1975 Mar; 214(1):86-91. PubMed ID: 1171660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in pharmacodynamics and pharmacokinetics of psycholeptic drugs in the course of radiation disease. Effects of premedication with cystamine on dynamics and kinetics of thioridazine.
    Wójciak Z; Kozaryn I; Chodera A; Szczawińska K; Cenajek D
    Acta Physiol Pol; 1977; 28(2):169-78. PubMed ID: 868535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenolic metabolites of thioridazine in man.
    Papadopoulos AS; Crammer JL; Cowan DA
    Xenobiotica; 1985 Apr; 15(4):309-16. PubMed ID: 4024665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of human cytochrome p450 enzymes involved in the metabolism of the piperidine-type phenothiazine neuroleptic thioridazine.
    Wójcikowski J; Maurel P; Daniel WA
    Drug Metab Dispos; 2006 Mar; 34(3):471-6. PubMed ID: 16272405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UVA-induced genetic effects of thioridazine, mesoridazine and sulforidazine: an in vitro study.
    Schoonderwoerd SA; Beijersbergen van Henegouwen GM; Panday IR
    Z Naturforsch C J Biosci; 1990 Jun; 45(6):638-44. PubMed ID: 2205215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thioridazine and the neuroleptic radioreceptor assay.
    Mailman RB; Pierce JP; Crofton KM; Petitto J; DeHaven DL; Kilts CD; Lewis MH
    Biol Psychiatry; 1984 Jun; 19(6):833-47. PubMed ID: 6743721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of thioridazine on gap junction intercellular communication in connexin 43-expressing cells.
    Matesic DF; Abifadel DN; Garcia EL; Jann MW
    Cell Biol Toxicol; 2006 Jul; 22(4):257-68. PubMed ID: 16685461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential liabilities of haloperidol and thioridazine for inducing apomorphine hypersensitivity.
    De Veaugh-Geiss J; Devanand DP; Carey RJ
    Biol Psychiatry; 1982 Nov; 17(11):1289-301. PubMed ID: 6891268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Site of action of thioridazine.
    Borison RL; Blowers AJ
    Lancet; 1982 Oct; 2(8303):883. PubMed ID: 6126746
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of selective cytochrome P-450 inhibitors on the metabolism of thioridazine. In vitro studies.
    Daniel WA; Syrek M; Haduch A
    Pol J Pharmacol; 1999; 51(5):435-42. PubMed ID: 10817545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.